Humoral immune response and safety of Sars-Cov-2 vaccine in people with multiple sclerosis

SS Hamzavi, R Bahrololoom, S Saeb, NH Marandi… - BMC immunology, 2024 - Springer
Background For the past three years, the pandemic has had a major effect on global public
health, mainly on those with underlying medical conditions, such as people living with …

[HTML][HTML] Response to clinical outcomes of solid organ transplant recipients hospitalized with COVID-19: a propensity score-matched cohort study

S Bhattacharya - Infection & Chemotherapy, 2024 - pmc.ncbi.nlm.nih.gov
Response to Clinical Outcomes of Solid Organ Transplant Recipients Hospitalized with
COVID-19: A Propensity Score-Matched Cohort Study - PMC Skip to main content Here's how …

Long Term Follow Up of Antibody Titres Against SARS-CoV-2 6 Months After Primary Protein Subunit COVID-19 Vaccination (ZF2001) in Indonesian Adults and Older …

RT Girsang, E Fadlyana, K Rusmil… - Open Access Journal …, 2024 - Taylor & Francis
Nearly 3 years after the emergence of COVID-19, it remains one of the world's problems.
COVID-19 vaccination is a priority programme for reducing death and severe symptoms. The …

Application and Significance of SIRVB Model in Analyzing COVID-19 Dynamics

P Ariyaratne, LP Ramasinghe, JS Ayyash, TM Kelley… - medRxiv, 2024 - medrxiv.org
In the summer of 2024, COVID-19 positive cases spiked in many countries, but it is no longer
a deadly pandemic thanks to global herd immunity to the SARS-CoV-2 viruses. In our …